Lipocalin-2 as a prognostic biomarker and its association with systemic inflammation in small cell lung cancer.

Se-Il GoJung Wook YangWoo Je LeeEun Jeong JeongSungwoo ParkGyeong-Won Lee

Published in: Thoracic cancer (2024)

High lipocalin-2 expression is potentially associated with poorer survival in LD-SCLC. Combining lipocalin-2 with other inflammation-related markers could improve prognostic stratification.

Keyphrases

small cell lung cancer
poor prognosis
oxidative stress
brain metastases
free survival
long non coding rna